Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
10
Bearish filings
18
Named actors
13
Disclosed $ (bull / bear)
$30.0M + 6 of unknown size / $614K + 5 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-10-09 | 5%+ holder (13G) Frazier Life Sciences Public Fund, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-10-06 | CFO and President Kalowski Lee | sold | $11K | SEC ↗ |
| 2026-10-06 | Chief Scientific Officer Violette Shelia M. | sold | $8K | SEC ↗ |
| 2026-10-06 | CEO Morrison Jodie Pope | sold | $27K | SEC ↗ |
| 2026-08-25 | Chief Scientific Officer Violette Shelia M. | sold | $46K | SEC ↗ |
3 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-08-25 | CEO Morrison Jodie Pope | sold | $163K | SEC ↗ |
| 2026-08-25 | CFO and President Kalowski Lee | sold | $66K | SEC ↗ |
| 2026-07-15 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-07-13 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-07-10 | 5%+ holder (13G) Boxer Capital Management, LLC | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-06-04 | 5%+ holder (13G) BIOTECHNOLOGY VALUE FUND L P | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-06-04 | 5%+ holder (13G) RA CAPITAL MANAGEMENT, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-05-28 | Director ORBIMED ADVISORS LLC | bought | $10.0M | SEC ↗ |
| 2026-05-28 | Director ORBIMED ADVISORS LLC | bought | $5.0M | SEC ↗ |
| 2026-05-28 | Director Xu Diyong | bought | $10.0M | SEC ↗ |
| 2026-05-28 | Director Xu Diyong | bought | $5.0M | SEC ↗ |
| 2026-04-24 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-03-27 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-02-25 | Chief Scientific Officer Violette Shelia M. | sold | $13K | SEC ↗ |
| 2026-02-25 | CEO Morrison Jodie Pope | sold | $45K | SEC ↗ |
| 2026-02-25 | CFO and President Kalowski Lee | sold | $18K | SEC ↗ |
| 2026-02-20 | 5%+ holder (13G) Opaleye Management Inc. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-02-19 | 5%+ holder (13G) Point72 Asset Management, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-02-17 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2025-12-02 | CFO and President Kalowski Lee | sold | $31K | SEC ↗ |